Nucleic acid extractor
01 January, 2009 | Supplied by: Beckman Coulter Australia
The Spri-te nucleic acid extractor for the automated purification of DNA and RNA prepares between one and 10 samples in about 30 minutes and requires minimal user training.
Diagnostic test for ovarian cancer
01 January, 2009 | Supplied by: Manalto Inc
The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.
Automated UV/vis colony counter
01 January, 2009 | Supplied by: Life Technologies
Synbiosis has released a multi-application Protocol UV automated colony counting and zone measurement system. This can rapidly and accurately count colonies or image zones illuminated by UV or white light.
Gene expression system
01 January, 2009 | Supplied by: Capsugel Australia Pty Ltd
The StellARray Gene Expression System consists of three products: the GeneSieve Query; the StellARray qPCR 96/384-well Arrays; and the Global Pattern Recognition (GPR) analysis tool.
Short read de novo analysis
01 January, 2009 | Supplied by: Applied Biosystems Pty Ltd
Applied Biosystems has expanded its suite of bioinformatics solutions to include de novo assembly of small organisms on the Solid 3 System, the company’s sequencing platform that enables the comprehensive analysis of genomes, transcriptomes and epigenomes.
Microplate readers
01 January, 2009 | Supplied by: BMG LABTECH Pty Ltd
The Omega series, including the Fluostar Omega and Polarstar Omega, is a microplate reader line that uses high-speed UV/vis spectrometer-based absorbance and filter-based detection in all measurement modes.
Molecular assay for K-ras
01 January, 2009 | Supplied by: QIAGEN Pty Ltd
Qiagen has launched a test to determine mutations of the K-ras gene, which can better define which metastatic colorectal cancer (CRC) patients will benefit from treatment with epidermal growth factor receptor (EGFR) inhibiting monoclonal antibodies, such as Amgen’s Vectibix (panitumumab) and Imclone/Bristol-Myers Squibb’s Erbitux (cetuximab).
PSA/fPSA immunoassay analysis
01 December, 2008 | Supplied by: Olympus Australia Pty Ltd
Olympus has released PSA and fPSA assays for the Olympus AU3000i immunoassay analyser. The assays feature assay sensitivity of 0.015 µg/L. In the monitoring of patients after prostate cancer treatment, the sensitive PSA assay is suitable for the detection of recurrence of the disease.
Faecal occult blood test
01 December, 2008 | Supplied by: Alere Australia
The ColonView quick test from Biohit can be used for identification of patients with faecal occult blood, a known marker for colorectal cancer and pre-cancerous large adenomas. ColonView testing can also give information on other possible diseases of the gastrointestinal tract that are associated with bleeding.
Big demand for biochips
11 November, 2008
Ten percent plus growth is forecast for the biochip market in the US, with demand being led from the drug discovery sector.
Australian gene technology launched in US
10 November, 2008
A microarray that consists of both mRNA and non-coding RNA content which helps to elucidate the function of specific non-coding RNAs in relation to known pathways of gene expression has been invented at UQ and now marketed to the US.
Automated gentle tissue dissociator
08 September, 2008 | Supplied by: http://www.miltenyibiotec.com
The gentleMACS dissociator is a benchtop instrument for the automated dissociation of tissues. The instrument offers programs for a variety of specific applications.
Urine chemistry analyser
01 September, 2008 | Supplied by: Siemens Ltd
The Siemens Healthcare Diagnostics Clinitek Advantus Urine chemistry analyser enables automated reading of Siemens’ Multistix family of urinalysis testing strips in medium to high throughput settings.
Rapid tests for drug-resistant TB
01 September, 2008
People in low-resource countries who are ill with multidrug-resistant TB (MDR-TB) will get a faster diagnosis — in two days, not the standard two to three months — and appropriate treatment due to two initiatives by WHO, the Stop TB Partnership, UNITAID and the Foundation for Innovative New Diagnostics (FIND).
cDNA synthesis kit
01 July, 2008 | Supplied by: Life Technologies
The SuperScript Vilo cDNA synthesis kit provides reliable and sensitive first strand cDNA synthesis. The kit uses RNAse H reduced SuperScript III Reverse Transcriptase, generating greatly increased yields of cDNA and improving qPCR sensitivity.
